Sensei Biotherapeutics, Inc. (SNSE) Misses Q3 EPS by 4c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies